Evidence map›Paper›PMID 18210993›Full record

ArticleJournal of the American Association for Laboratory Animal Science : JAALAS2008

Field trial of a Pasteurella multocida extract vaccine in rabbits.

Mark A Suckow, Rudolph W Haab, Lawrence J Miloscio, Norman B Guilloud

Open access · greenAbstract readControlled Clinical Trial
In one paragraph

Article in Journal of the American Association for Laboratory Animal Science : JAALAS, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. In field evaluation of impact on clinical signs of an inactivated autogenous vaccine againstInternational journal of veterinary science and medicine · 2024
    Article
  2. Article
  3. Article
  4. Avicenna journal of medical biotechnology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Mark A SuckowLaboratory Animal program, Purdue University, West lafayette, IN, USA. suckow.1@nd.edu
Rudolph W Haab
Lawrence J Miloscio
Norman B Guilloud
Purdue University West Lafayette · USRegeneron (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pasteurella multocida is a bacterial pathogen that can cause significant disease and subsequent effects on research activities involving rabbits. Although several vaccines have been tested under laboratory conditions, field trials of vaccines for the control of P. multocida in rabbits are few. We used a potassium thiocyanate extract (PTE) produced from P. multocida serotype D:3,12,15 to vaccinate Pasteurella-free rabbits at their introduction into a colony having endemic infection with P. multocida serotype A:3. Groups of 15 rabbits were vaccinated either SC or IN with 1.0 mg PTE once weekly for 3 wk. In addition a control group was sham-vaccinated IN with saline. After the last vaccine dose had been administered, rabbits were housed with the general colony of a facility with endemic pasteurellosis. Serum samples obtained before and 5 and 24 wk after the first dose of vaccine were evaluated by ELISA for anti-PTE IgG. Rabbits were euthanized if found in poor clinical condition, and all remaining rabbits were euthanized 24 wk after initial vaccination. Clinical disease typical of P. multocida infection was observed in 10 of 15 saline-vaccinated rabbits, 4 of 15 IN PTE-vaccinated rabbits, and 1 of 15 SC PTE-vaccinated rabbits. Bacterial culture of the nasopharynx at the time of necropsy was positive for P. multocida in 10 of 15 control rabbits, 5 of 15 IN PTE-vaccinated rabbits, and 1 of 15 SC PTE-vaccinated rabbits. Anti-PTE serum IgG activity had developed in both IN- and SC-vaccinated rabbits by 5 wk, with significantly lower activity by 24 wk after initial vaccination. IgG activity was significantly greater in rabbits vaccinated SC compared with controls or those vaccinated IN. In summary, PTE can be used to stimulate protective immunity to a heterologous strain of P. multocida, with stronger immunity generated by SC than IN vaccination.

Indexed as

AnimalsAntibodies, BacterialBacterial ProteinsBacterial VaccinesFemaleLiverLungNasopharynxPasteurella InfectionsPasteurella multocidaRabbitsThiocyanatesVaccinationAntibodies, BacterialBacterial ProteinsBacterial VaccinesThiocyanates

Identifiers

PMID18210993
PMCPMC2652619
OpenAlexW2993933866

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.